MSN: Moviprep® and Plenvu® oral powder sachets, beclometasone dipropionate (Clenil Modulite®) 50micrograms/dose, formoterol fumarate dihydrate

DHSC has issued tier 2 Medicine Supply Notifications (MSN) for the following items:

Moviprep® and Plenvu® oral powder sachets: limited supply until January 2027.
Beclometasone dipropionate (Clenil Modulite®) 50micrograms/dose and 250 micrograms/dose inhalers: discontinued at the end of November 2026.
Formoterol fumarate dihydrate (Atimos Modulite®) 12micrograms/dose inhaler: discontinued at the end of November 2026

Up-to-date information about this and other medicine supply issues can be found in the DHSC and NHSE online Medicines Supply Tool

Supply Shortages

Latest news

Reduce the medication-related 'nocebo' effect

Expressing medication risk using percentages can help reduce the ‘nocebo’ effect of negative expectations about medication, a new study from Spain suggests. Factors affecting the likelihood of documented medication concerns in patients w

MSN: Moviprep® and Plenvu® oral powder sachets, beclometasone dipropionate (Clenil Modulite®) 50micrograms/dose, formoterol fumarate dihydrate

DHSC has issued tier 2 Medicine Supply Notifications (MSN) for the following items: Moviprep® and Plenvu® oral powder sachets: limited supply until January 2027. Beclometasone dipropionate (Clenil Modulite®) 50microgra

Rybelsus price redetermination

The Department of Health and Social Care has confirmed that the reimbursement price for the following products in the Drug Tariff Part VIIIA Category C has been redetermined for the month of August. This is to reflect an increase in the NHS list pri